{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T01:06:41Z","timestamp":1773623201407,"version":"3.50.1"},"reference-count":61,"publisher":"Pleiades Publishing Ltd","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochemistry Moscow"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1134\/s000629792560070x","type":"journal-article","created":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T15:56:43Z","timestamp":1756483003000},"page":"1049-1063","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Double Toxic MPTP+CBE Presymptomatic Parkinson-Like Phenotype in Mice"],"prefix":"10.1134","volume":"90","author":[{"given":"Sofya N.","family":"Pchelina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anastasia I.","family":"Bezrukova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita M.","family":"Rudenok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander S.","family":"Zhuravlev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan N.","family":"Rybolovlev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna O.","family":"Lavrinova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galina V.","family":"Baydakova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikhail A.","family":"Nikolaev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maxim S.","family":"Nesterov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis A.","family":"Abaimov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria N.","family":"Pidurchina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suzanna A.","family":"Partevyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina I.","family":"Semenova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatiana S.","family":"Usenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ekaterina Y.","family":"Zakharova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anton K.","family":"Emelyanov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria I.","family":"Shadrina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr A.","family":"Slominsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"137","published-online":{"date-parts":[[2025,8,29]]},"reference":[{"key":"2892_CR1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1090278","volume":"302","author":"A. B. Singleton","year":"2003","unstructured":"Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., Lincoln, S., Crawley, A., Hanson, M., Maraganore, D., Adler, C., Cookson, M. R., Muenter, M., Baptista, M., Miller, D., Blancato, J., Hardy, J., and Gwinn-Hardy, K. (2003) Alpha-synuclein locus triplication causes Parkinson\u2019s disease, Science, 302, 841, \nhttps:\/\/doi.org\/10.1126\/science.1090278.","journal-title":"Science"},{"key":"2892_CR2","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1212\/01.wnl.0000127517.33208.f4","volume":"62","author":"D. W. Miller","year":"2004","unstructured":"Miller, D. W., Hague, S. M., Clarimon, J., Baptista, M., Gwinn-Hardy, K., Cookson, M. R., and Singleton, A. B. (2004) Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication, Neurology, 62, 1835-1838, \nhttps:\/\/doi.org\/10.1212\/01.wnl.0000127517.33208.f4.","journal-title":"Neurology"},{"key":"2892_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/ana.23746","volume":"73","author":"L. V. Kalia","year":"2013","unstructured":"Kalia, L. V., Kalia, S. K., McLean, P. J., Lozano, A. M., and Lang, A. E. (2013) \u03b1-Synuclein oligomers and clinical implications for Parkinson disease, Ann. Neurol., 73, 155-169, \nhttps:\/\/doi.org\/10.1002\/ana.23746.","journal-title":"Ann. Neurol."},{"key":"2892_CR4","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1093\/hmg\/9.18.2683","volume":"9","author":"S. J. Tabrizi","year":"2000","unstructured":"Tabrizi, S. J., Orth, M., Wilkinson, J. M., Taanman, J. W., Warner, T. T., Cooper, J. M., and Schapira, A. H. (2000) Expression of mutant alpha-synuclein causes increased susceptibility to dopamine toxicity, Hum. Mol. Genet., 9, 2683-2689, \nhttps:\/\/doi.org\/10.1093\/hmg\/9.18.2683.","journal-title":"Hum. Mol. Genet."},{"key":"2892_CR5","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/ajh.24491","volume":"91","author":"V. Murugesan","year":"2016","unstructured":"Murugesan, V., Chuang, W. L., Liu, J., Lischuk, A., Kacena, K., Lin, H., Pastores, G. M., Yang, R., Keutzer, J., Zhang, K., and Mistry, P. K. (2016) Glucosylsphingosine is a key biomarker of Gaucher disease, Am. J. Hematol., 91, 1082-1089, \nhttps:\/\/doi.org\/10.1002\/ajh.24491.","journal-title":"Am. J. Hematol."},{"key":"2892_CR6","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1515\/cclm-2018-1301","volume":"57","author":"G. Polo","year":"2019","unstructured":"Polo, G., Burlina, A. P., Ranieri, E., Colucci, F., Rubert, L., Pascarella, A., Duro, G., Tummolo, A., Padoan, A., Plebani, M., and Burlina, A. B. (2019) Plasma and dried blood spot lysosphingolipids for the diagnosis of different sphingolipidoses: a comparative study, Clin. Chem. Lab. Med., 57, 1863-1874, \nhttps:\/\/doi.org\/10.1515\/cclm-2018-1301.","journal-title":"Clin. Chem. Lab. Med."},{"key":"2892_CR7","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","volume":"361","author":"E. Sidransky","year":"2009","unstructured":"Sidransky, E., Nalls, M. A., Aasly, J. O., Aharon-Peretz, J., Annesi, G., Barbosa, E. R., Bar-Shira, A., Berg, D., Bras, J., Brice, A., Chen, C. M., Clark, L. N., Condroyer, C., De Marco, E. V., D\u00fcrr, A., Eblan, M. J., Fahn, S., Farrer, M. J., Fung, H. C., Gan-Or, Z., Gasser, T., Gershoni-Baruch, R., Giladi, N., Griffith, A., Gurevich, T., Januario, C., Kropp, P., Lang, A. E., Lee-Chen, G. J., Lesage, S., Marder, K., Mata, I. F., Mirelman, A\/, Mitsui, J., Mizuta, I., Nicoletti, G., Oliveira, C., Ottman, R., Orr-Urtreger, A., Pereira, L. V., Quattrone, A., Rogaeva, E., Rolfs, A., Rosenbaum, H., Rozenberg, R., Samii, A., Samaddar, T., Schulte, C., Sharma, M., Singleton, A., Spitz, M., Tan, E. K., Tayebi, N., Toda, T., Troiano, A. R., Tsuji, S., Wittstock, M., Wolfsberg, T. G., Wu, Y. R., Zabetian, C. P., Zhao, Y., and Ziegler, S. G. (2009) Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease, N. Engl. J. Med., 361, 1651-1661, \nhttps:\/\/doi.org\/10.1056\/NEJMoa0901281.","journal-title":"N. Engl. J. Med."},{"key":"2892_CR8","doi-asserted-by":"publisher","first-page":"267.e7","DOI":"10.1016\/j.neurobiolaging.2018.06.027","volume":"71","author":"A. K. Emelyanov","year":"2018","unstructured":"Emelyanov, A. K., Usenko, T. S., Tesson, C., Senkevich, K. A., Nikolaev, M. A., Miliukhina, I. V., Kopytova, A. E., Timofeeva, A. A., Yakimovsky, A. F., Lesage, S., Brice, A., and Pchelina, S. N. (2018) Mutation analysis of Parkinson\u2019s disease genes in a Russian data set, Neurobiol. Aging, 71, 267.e7-267.e10, \nhttps:\/\/doi.org\/10.1016\/j.neurobiolaging.2018.06.027.","journal-title":"Neurobiol. Aging"},{"key":"2892_CR9","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1212\/WNL.0000000000001315","volume":"84","author":"Z. Gan-Or","year":"2015","unstructured":"Gan-Or, Z., Amshalom, I., Kilarski, L. L., Bar-Shira, A., Gana-Weisz, M., Mirelman, A., Marder, K., Bressman, S., Giladi, N., and Orr-Urtreger, A. (2015) Differential effects of severe vs mild GBA mutations on Parkinson disease, Neurology, 84, 880-887, \nhttps:\/\/doi.org\/10.1212\/WNL.0000000000001315.","journal-title":"Neurology"},{"key":"2892_CR10","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1093\/brain\/awv179","volume":"138","author":"R. N. Alcalay","year":"2015","unstructured":"Alcalay, R. N., Levy, O. A., Waters, C. C., Fahn, S., Ford, B., Kuo, S. H., Mazzoni, P., Pauciulo, M. W., Nichols, W. C., Gan-Or, Z., Rouleau, G. A., Chung, W. K., Wolf, P., Oliva, P., Keutzer, J., Marder, K., and Zhang, X. (2015) Glucocerebrosidase activity in Parkinson\u2019s disease with and without GBA mutations, Brain, 138, 2648-2658, \nhttps:\/\/doi.org\/10.1093\/brain\/awv179.","journal-title":"Brain"},{"key":"2892_CR11","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.parkreldis.2017.08.026","volume":"44","author":"L. C. Guedes","year":"2017","unstructured":"Guedes, L. C., Chan, R. B., Gomes, M. A., Concei\u00e7\u00e3o, V. A., Machado, R. B., Soares, T., Xu, Y., Gaspar, P., Carri\u00e7o, J. A., Alcalay, R. N., Ferreira, J. J., Outeiro, T. F., and Miltenberger-Miltenyi, G. (2017) Serum lipid alterations in GBA-associated Parkinson\u2019s disease, Parkinsonism Relat. Disord., 44, 58-65, \nhttps:\/\/doi.org\/10.1016\/j.parkreldis.2017.08.026.","journal-title":"Parkinsonism Relat. Disord."},{"key":"2892_CR12","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/mds.27393","volume":"33","author":"S. Pchelina","year":"2018","unstructured":"Pchelina, S., Baydakova, G., Nikolaev, M., Senkevich, K., Emelyanov, A., Kopytova, A., Miliukhina, I., Yakimovskii, A., Timofeeva, A., Berkovich, O., Fedotova, E., Illarioshkin, S., and Zakharova, E. (2018) Blood lysosphingolipids accumulation in patients with parkinson\u2019s disease with glucocerebrosidase 1 mutations, Mov. Disord., 33, 1325-1330, \nhttps:\/\/doi.org\/10.1002\/mds.27393.","journal-title":"Mov. Disord."},{"key":"2892_CR13","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neulet.2016.10.039","volume":"636","author":"S. Pchelina","year":"2017","unstructured":"Pchelina, S., Emelyanov, A., Baydakova, G., Andoskin, P., Senkevich, K., Nikolaev, M., Miliukhina, I., Yakimovskii, A., Timofeeva, A., Fedotova, E., Abramycheva, N., Usenko, T., Kulabukhova, D., Lavrinova, A., Kopytova, A., Garaeva, L., Nuzhnyi, E., Illarioshkin, S., and Zakharova, E. (2017) Oligomeric \u03b1-synuclein and glucocerebrosidase activity levels in GBA-associated Parkinson\u2019s disease, Neurosci. Lett., 636, 70-76, \nhttps:\/\/doi.org\/10.1016\/j.neulet.2016.10.039.","journal-title":"Neurosci. Lett."},{"key":"2892_CR14","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1002\/mds.29132","volume":"37","author":"A. E. Kopytova","year":"2022","unstructured":"Kopytova, A. E., Usenko, T. S., Baydakova, G. V., Nikolaev, M. A., Senkevich, K. A., Izyumchenko, A. D., Tyurin, A. A., Miliukhina, I. V., Emelyanov, A. K., Zakharova, E. Y., and Pchelina, S. N. (2022) Could blood hexosylsphingosine be a marker for Parkinson\u2019s disease linked with GBA1 mutations? Mov. Disord., 37, 1779-1781, \nhttps:\/\/doi.org\/10.1002\/mds.29132.","journal-title":"Mov. Disord."},{"key":"2892_CR15","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1002\/mds.26200","volume":"30","author":"E. Nuzhnyi","year":"2015","unstructured":"Nuzhnyi, E., Emelyanov, A., Boukina, T., Usenko, T., Yakimovskii, A., Zakharova, E., and Pchelina, S. (2015) Plasma oligomeric alpha-synuclein is associated with glucocerebrosidase activity in Gaucher disease, Mov. Disord., 30, 989-991, \nhttps:\/\/doi.org\/10.1002\/mds.26200.","journal-title":"Mov. Disord."},{"key":"2892_CR16","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.neulet.2014.09.041","volume":"583","author":"S. N. Pchelina","year":"2014","unstructured":"Pchelina, S. N., Nuzhnyi, E. P., Emelyanov, A. K., Boukina, T. M., Usenko, T. S., Nikolaev, M. A., Salogub, G. N., Yakimovskii, A. F., and Zakharova, E. Y. (2014) Increased plasma oligomeric alpha-synuclein in patients with lysosomal storage diseases, Neurosci. Lett., 583, 188-193, \nhttps:\/\/doi.org\/10.1016\/j.neulet.2014.09.041.","journal-title":"Neurosci. Lett."},{"key":"2892_CR17","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/mds.28496","volume":"36","author":"M. Avenali","year":"2021","unstructured":"Avenali, M., Cerri, S., Ongari, G., Ghezzi, C., Pacchetti, C., Tassorelli, C., Valente, E. M., and Blandini, F. (2021) Profiling the biochemical signature of GBA-related Parkinson\u2019s disease in peripheral blood mononuclear cells, Mov. Disord., 36, 1267-1272, \nhttps:\/\/doi.org\/10.1002\/mds.28496.","journal-title":"Mov. Disord."},{"key":"2892_CR18","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1002\/mds.28688","volume":"36","author":"A. Emelyanov","year":"2021","unstructured":"Emelyanov, A., Usenko, T., Nikolaev, M., Senkevich, K., Kulabukhova, D., Lavrinova, A., Andoskin, P., Miliukhina, I., and Pchelina, S. (2021) Increased \u03b1-synuclein level in CD45+ blood cells in asymptomatic carriers of GBA mutations, Mov. Disord., 36, 1997-1998, \nhttps:\/\/doi.org\/10.1002\/mds.28688.","journal-title":"Mov. Disord."},{"key":"2892_CR19","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.stemcr.2016.01.013","volume":"6","author":"H. J. Fernandes","year":"2016","unstructured":"Fernandes, H. J., Hartfield, E. M., Christian, H. C., Emmanoulidou, E., Zheng, Y., Booth, H., Bogetofte, H., Lang, C., Ryan, B. J., Sardi, S. P., Badger, J., Vowles, J., Evetts, S., Tofaris, G. K., Vekrellis, K., Talbot, K., Hu, M. T., James, W., Cowley, S. A., and Wade-Martins, R. (2016) ER stress and autophagic perturbations lead to elevated extracellular \u03b1-synuclein in GBA-N370S Parkinson\u2019s iPSC-derived dopamine neurons, Stem Cell Rep., 6, 342-356, \nhttps:\/\/doi.org\/10.1016\/j.stemcr.2016.01.013.","journal-title":"Stem Cell Rep."},{"key":"2892_CR20","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1093\/brain\/awu291","volume":"137","author":"I. Fishbein","year":"2014","unstructured":"Fishbein, I., Kuo, Y. M., Giasson, B. I., and Nussbaum, R. L. (2014) Augmentation of phenotype in a transgenic Parkinson mouse heterozygous for a Gaucher mutation, Brain, 137, 3235-3247, \nhttps:\/\/doi.org\/10.1093\/brain\/awu291.","journal-title":"Brain"},{"key":"2892_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-017-0233-5","volume":"13","author":"S. P. Yun","year":"2018","unstructured":"Yun, S. P., Kim, D., Kim, S., Kim, S., Karuppagounder, S. S., Kwon, S. H., Lee, S., Kam, T. I., Lee, S., Ham, S., Park, J. H., Dawson, V. L., Dawson, T. M., Lee, Y., and Ko, H. S. (2018) \u03b1-Synuclein accumulation and GBA deficiency due to L444P GBA mutation contributes to MPTP-induced parkinsonism, Mol. Neurodegener., 13, 1, \nhttps:\/\/doi.org\/10.1186\/s13024-017-0233-5.","journal-title":"Mol. Neurodegener."},{"key":"2892_CR22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/B978-0-12-374028-1.00003-8","volume":"3","author":"J. Schneider","year":"2008","unstructured":"Schneider, J., Anderson, D., and Decamp, E. (2008) Neuropathology of Parkinson\u2019s disease, Parkinson\u2019s Dis., 3, 87-104, \nhttps:\/\/doi.org\/10.1016\/B978-0-12-374028-1.00003-8.","journal-title":"Parkinson\u2019s Dis."},{"key":"2892_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.nbd.2018.12.001","volume":"124","author":"L. Mus","year":"2019","unstructured":"Mus, L., Siani, F., Giuliano, C., Ghezzi, C., Cerri, S., and Blandini, F. (2019) Development and biochemical characterization of a mouse model of Parkinson\u2019s disease bearing defective glucocerebrosidase activity, Neurobiol. Dis., 124, 289-296, \nhttps:\/\/doi.org\/10.1016\/j.nbd.2018.12.001.","journal-title":"Neurobiol. Dis."},{"key":"2892_CR24","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1016\/j.neuro.2009.06.009","volume":"30","author":"A. B. Manning-Bo\u011f","year":"2009","unstructured":"Manning-Bo\u011f, A. B., Sch\u00fcle, B., and Langston, J. W. (2009) Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: a biological link between Gaucher disease and parkinsonism, Neurotoxicology, 30, 1127-1132, \nhttps:\/\/doi.org\/10.1016\/j.neuro.2009.06.009.","journal-title":"Neurotoxicology"},{"key":"2892_CR25","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1002\/(SICI)1097-4547(19960201)43:3<365::AID-JNR11>3.0.CO;2-4","volume":"43","author":"E. M. Prence","year":"1996","unstructured":"Prence, E. M., Chaturvedi, P., and Newburg, D. S. (1996) In\u00a0vitro accumulation of glucocerebroside in neuroblastoma cells: a model for study of Gaucher disease pathobiology, J. Neurosci. Res., 43, 365-371, \nhttps:\/\/doi.org\/10.1002\/(SICI)1097-4547(19960201)43:3<365::AID-JNR11>3.0.CO;2-4.","journal-title":"J. Neurosci. Res."},{"key":"2892_CR26","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0006-291x(75)90286-7","volume":"67","author":"J. N. Kanfer","year":"1975","unstructured":"Kanfer, J. N., Legler, G., Sullivan, J., Raghavan, S. S., and Mumford, RA. (1975) The Gaucher mouse, Biochem. Biophys. Res. Commun., 67, 85-90, \nhttps:\/\/doi.org\/10.1016\/0006-291x(75)90286-7.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2892_CR27","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1242\/dmm.008185","volume":"4","author":"T. Farfel-Becker","year":"2011","unstructured":"Farfel-Becker, T., Vitner, E. B., and Futerman, A. H. (2011) Animal models for Gaucher disease research, Dis. Model. Mech., 4, 746-752, \nhttps:\/\/doi.org\/10.1242\/dmm.008185.","journal-title":"Dis. Model. Mech."},{"key":"2892_CR28","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1016\/j.celrep.2016.07.085","volume":"16","author":"A. D. Klein","year":"2016","unstructured":"Klein, A. D., Ferreira, N. S., Ben-Dor, S., Duan, J., Hardy, J., Cox, T. M., Merrill, A. H., Jr., and Futerman, A. H. (2016) Identification of modifier genes in a mouse model of Gaucher disease, Cell Rep., 16, 2546-2553, \nhttps:\/\/doi.org\/10.1016\/j.celrep.2016.07.085.","journal-title":"Cell Rep."},{"key":"2892_CR29","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/path.4751","volume":"239","author":"A. Vardi","year":"2016","unstructured":"Vardi, A., Zigdon, H., Meshcheriakova, A., Klein, A. D., Yaacobi, C., Eilam, R., Kenwood, B. M., Rahim, A. A., Massaro, G., Merrill, A. H. Jr, Vitner, E. B., and Futerman, A. H. (2016) Delineating pathological pathways in a chemically induced mouse model of Gaucher disease, J.\u00a0Pathol., 239, 496-509, \nhttps:\/\/doi.org\/10.1002\/path.4751.","journal-title":"J.\u00a0Pathol."},{"key":"2892_CR30","doi-asserted-by":"publisher","first-page":"6775","DOI":"10.1007\/s12035-016-0190-y","volume":"54","author":"A. K. Alieva","year":"2017","unstructured":"Alieva, A. K., Filatova, E. V., Kolacheva, A. A., Rudenok, M. M., Slominsky, P. A., Ugrumov, M. V., and Shadrina, M. I. (2017) Transcriptome profile changes in mice with MPTP-induced early stages of Parkinson\u2019s disease, Mol. Neurobiol., 54, 6775-6784, \nhttps:\/\/doi.org\/10.1007\/s12035-016-0190-y.","journal-title":"Mol. Neurobiol."},{"key":"2892_CR31","doi-asserted-by":"publisher","first-page":"7229","DOI":"10.1007\/s12035-018-0907-1","volume":"55","author":"A. K. Alieva","year":"2018","unstructured":"Alieva, A. K., Zyrin, V. S., Rudenok, M. M., Kolacheva, A. A., Shulskaya, M. V., Ugryumov, M. V., Slominsky, P. A., and Shadrina, M. I. (2018) Whole-transcriptome analysis of mouse models with MPTP-induced early stages of Parkinson\u2019s disease reveals stage-specific response of transcriptome and a possible role of myelin-linked genes in neurodegeneration, Mol. Neurobiol., 55, 7229-7241, \nhttps:\/\/doi.org\/10.1007\/s12035-018-0907-1.","journal-title":"Mol. Neurobiol."},{"key":"2892_CR32","doi-asserted-by":"publisher","first-page":"8090","DOI":"10.1007\/s12035-016-0261-0","volume":"54","author":"J. A. Lenihan","year":"2017","unstructured":"Lenihan, J. A., Saha, O., Heimer-McGinn, V., Cryan, J. F., Feng, G., and Young, P. W. (2017) Decreased anxiety-related behaviour but apparently unperturbed NUMB function in ligand of NUMB protein-X (LNX) 1\/2 double knockout mice, Mol. Neurobiol., 54, 8090-8109, \nhttps:\/\/doi.org\/10.1007\/s12035-016-0261-0.","journal-title":"Mol. Neurobiol."},{"key":"2892_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1134\/S0044467719010064","volume":"69","author":"G. I. Kovalev","year":"2019","unstructured":"Kovalev, G. I., Vasileva, E. V., and Salimov, R. M. (2019) Comparison of mouse behavior in the open field, closed and elevated cross-maze tests by the use of factor analysis, Zh. Vyssh. Nervn. Deyat. im.\u00a0I. P. Pavlova, 69, 123-130, \nhttps:\/\/doi.org\/10.1134\/S0044467719010064.","journal-title":"Zh. Vyssh. Nervn. Deyat. im.\u00a0I. P. Pavlova"},{"key":"2892_CR34","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1515\/cclm-2016-0340","volume":"55","author":"G. Polo","year":"2017","unstructured":"Polo, G., Burlina, A. P., Kolamunnage, T. B., Zampieri, M., Dionisi-Vici, C., Strisciuglio, P., Zaninotto, M., Plebani, M., and Burlina, A. B. (2017) Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS\/MS, Clin. Chem. Lab. Med., 55, 403-414, \nhttps:\/\/doi.org\/10.1515\/cclm-2016-0340.","journal-title":"Clin. Chem. Lab. Med."},{"key":"2892_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24109105","volume":"24","author":"A. E. Kopytova","year":"2023","unstructured":"Kopytova, A. E., Rychkov, G. N., Cheblokov, A. A., Grigor\u2019eva, E. V., Nikolaev, M. A., Yarkova, E. S., Sorogina, D. A., Ibatullin, F. M., Baydakova, G. V., Izyumchenko, A. D., Bogdanova, D. A., Boitsov, V. M., Rybakov, A. V., Miliukhina, I. V., Bezrukikh, V. A., Salogub, G. N., Zakharova, E. Y., Pchelina, S. N., and Emelyanov, A. K. (2023) Potential binding sites of pharmacological chaperone NCGC00241607 on mutant b-glucocerebrosidase and its efficacy on patient-derived cell cultures in Gaucher and Parkinson\u2019s disease, Int. J. Mol. Sci., 24, 9105, \nhttps:\/\/doi.org\/10.3390\/ijms24109105.","journal-title":"Int. J. Mol. Sci."},{"key":"2892_CR36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/978-1-61779-328-8_27","volume":"793","author":"L. Yang","year":"2011","unstructured":"Yang, L., and Beal, M. F. (2011) Determination of neurotransmitter levels in models of Parkinson\u2019s disease by HPLC-ECD, Methods Mol. Biol., 793, 401-415, \nhttps:\/\/doi.org\/10.1007\/978-1-61779-328-8_27.","journal-title":"Methods Mol. Biol."},{"key":"2892_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ab.2012.10.010","volume":"433","author":"A. G\u00fcrtler","year":"2013","unstructured":"G\u00fcrtler, A., Kunz, N., Gomolka, M., Hornhardt, S., Friedl, A. A., McDonald, K., Kohn, J. E., and Posch, A. (2013) Stain-free technology as a normalization tool in Western blot analysis, Anal. Biochem., 433, 105-111, \nhttps:\/\/doi.org\/10.1016\/j.ab.2012.10.010.","journal-title":"Anal. Biochem."},{"key":"2892_CR38","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/978-1-4939-2550-6_27","volume":"1295","author":"J. E. Gilda","year":"2015","unstructured":"Gilda, J. E., and Gomes, A. V. (2015) Western blotting using in-gel protein labeling as a normalization control: stain-free technology, Methods Mol. Biol., 1295, 381-391, \nhttps:\/\/doi.org\/10.1007\/978-1-4939-2550-6_27.","journal-title":"Methods Mol. Biol."},{"key":"2892_CR39","doi-asserted-by":"publisher","DOI":"10.3791\/3564","volume":"30","author":"G. J. Gage","year":"2012","unstructured":"Gage, G. J., Kipke, D. R., and Shain, W. (2012) Whole animal perfusion fixation for rodents, J.\u00a0Vis. Exp., 30, 3564, \nhttps:\/\/doi.org\/10.3791\/3564.","journal-title":"J.\u00a0Vis. Exp."},{"key":"2892_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280497","volume":"18","author":"M. Gavid","year":"2023","unstructured":"Gavid, M., Coulomb, L., Thomas, J., Aouimeur, I., Verhoeven, P., Mentek, M., Dumollard, J. M., Forest, F., Prades, J. M., Thuret, G., Gain, P., and He, Z. (2023) Technique of flat-mount immunostaining for mapping the olfactory epithelium and counting the olfactory sensory neurons, PLoS One, 18, e0280497, \nhttps:\/\/doi.org\/10.1371\/journal.pone.0280497.","journal-title":"PLoS One"},{"key":"2892_CR41","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuroscience.2011.03.007","volume":"181","author":"M. V. Ugrumov","year":"2011","unstructured":"Ugrumov, M. V., Khaindrava, V. G., Kozina, E. A., Kucheryanu, V. G., Bocharov, E. V., Kryzhanovsky, G. N., Kudrin, V. S., Narkevich, V. B., Klodt, P. M., Rayevsky, K. S., and Pronina, T. S. (2011) Modeling of presymptomatic and symptomatic stages of parkinsonism in mice, Neuroscience, 181, 175-188, \nhttps:\/\/doi.org\/10.1016\/j.neuroscience.2011.03.007.","journal-title":"Neuroscience"},{"key":"2892_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neulet.2006.03.017","volume":"401","author":"S. Ohashi","year":"2006","unstructured":"Ohashi, S., Mori, A., Kurihara, N., Mitsumoto, Y., and Nakai, M. (2006) Age-related severity of dopaminergic neurodegeneration to MPTP neurotoxicity causes motor dysfunction in C57BL\/6 mice, Neurosci. Lett., 401, 183-187, \nhttps:\/\/doi.org\/10.1016\/j.neulet.2006.03.017.","journal-title":"Neurosci. Lett."},{"key":"2892_CR43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/acn3.177","volume":"2","author":"E. M. Rocha","year":"2015","unstructured":"Rocha, E. M., Smith, G. A., Park, E., Cao, H., Brown, E., Hallett, P., and Isacson, O. (2015) Progressive decline of glucocerebrosidase in aging and Parkinson\u2019s disease, Ann. Clin. Transl. Neurol., 2, 433-438, \nhttps:\/\/doi.org\/10.1002\/acn3.177.","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"2892_CR44","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1093\/hmg\/ddy075","volume":"27","author":"V. E. Papadopoulos","year":"2018","unstructured":"Papadopoulos, V. E., Nikolopoulou, G., Antoniadou, I., Karachaliou, A., Arianoglou, G., Emmanouilidou, E., Sardi, S. P., Stefanis, L., and Vekrellis, K. (2018) Modulation of b-glucocerebrosidase increases \u03b1-synuclein secretion and exosome release in mouse models of Parkinson\u2019s disease, Hum. Mol. Genet., 27, 1696-1710, \nhttps:\/\/doi.org\/10.1093\/hmg\/ddy075.","journal-title":"Hum. Mol. Genet."},{"key":"2892_CR45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2108489118","volume":"118","author":"K. Fredriksen","year":"2021","unstructured":"Fredriksen, K., Aivazidis, S., Sharma, K., Burbidge, K. J., Pitcairn, C., Zunke, F., Gelyana, E., and Mazzulli, J. R. (2021) Pathological \u03b1-syn aggregation is mediated by glycosphingolipid chain length and the physiological state of \u03b1-syn in\u00a0vivo, Proc. Natl. Acad. Sci. USA, 118, e2108489118, \nhttps:\/\/doi.org\/10.1073\/pnas.2108489118.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"2892_CR46","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.adk8249","volume":"17","author":"R. Wang","year":"2024","unstructured":"Wang, R., Sun, H., Cao, Y., Zhang, Z., Chen, Y., Wang, X., Liu, L., Wu, J., Xu, H., Wu, D., Mu, C., Hao, Z., Qin, S., Ren, H., Han, J., Fang, M., and Wang, G. (2024) Glucosylceramide accumulation in microglia triggers STING-dependent neuroinflammation and neurodegeneration in mice, Sci. Signal., 17, eadk8249, \nhttps:\/\/doi.org\/10.1126\/scisignal.adk8249.","journal-title":"Sci. Signal."},{"key":"2892_CR47","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/ana.24790","volume":"80","author":"A. Migdalska-Richards","year":"2016","unstructured":"Migdalska-Richards, A., Daly, L., Bezard, E., and Schapira, A. H. (2016) Ambroxol effects in glucocerebrosidase and \u03b1-synuclein transgenic mice, Ann. Neurol., 80, 766-775, \nhttps:\/\/doi.org\/10.1002\/ana.24790.","journal-title":"Ann. Neurol."},{"key":"2892_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0538-9","volume":"6","author":"D. Kim","year":"2018","unstructured":"Kim, D., Hwang, H., Choi, S., Kwon, S. H., Lee, S., Park, J. H., Kim, S., and Ko, H. S. (2018) D409H GBA1 mutation accelerates the progression of pathology in A53T \u03b1-synuclein transgenic mouse model, Acta Neuropathol. Commun., 6, 32, \nhttps:\/\/doi.org\/10.1186\/s40478-018-0538-9.","journal-title":"Acta Neuropathol. Commun."},{"key":"2892_CR49","doi-asserted-by":"publisher","first-page":"2645","DOI":"10.1093\/hmg\/ddw124","volume":"25","author":"E. Rockenstein","year":"2016","unstructured":"Rockenstein, E., Clarke, J., Viel, C., Panarello, N., Treleaven, C. M., Kim, C., Spencer, B., Adame, A., Park, H., Dodge, J. C., Cheng, S. H., Shihabuddin, L. S., Masliah, E., and Sardi, S. P. (2016) Glucocerebrosidase modulates cognitive and motor activities in murine models of Parkinson\u2019s disease, Hum. Mol. Genet., 25, 2645-2660, \nhttps:\/\/doi.org\/10.1093\/hmg\/ddw124.","journal-title":"Hum. Mol. Genet."},{"key":"2892_CR50","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1080\/15548627.2015.1086055","volume":"11","author":"T. T. Du","year":"2015","unstructured":"Du, T. T., Wang, L., Duan, C. L., Lu, L. L., Zhang, J. L., Gao, G., Qiu, X. B., Wang, X. M., and Yang, H. (2015) GBA deficiency promotes SNCA\/\u03b1-synuclein accumulation through autophagic inhibition by inactivated PPP2A, Autophagy, 11, 1803-1820, \nhttps:\/\/doi.org\/10.1080\/15548627.2015.1086055.","journal-title":"Autophagy"},{"key":"2892_CR51","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.abm6393","volume":"8","author":"S. H. Kuo","year":"2022","unstructured":"Kuo, S. H., Tasset, I., Cheng, M. M., Diaz, A., Pan, M. K., Lieberman, O. J., Hutten, S. J., Alcalay, R. N., Kim, S., Xim\u00e9nez-Emb\u00fan, P., Fan, L., Kim, D., Ko, H. S., Yacoubian, T., Kanter, E., Liu, L., Tang, G., Mu\u00f1oz, J., Sardi, S. P., Li, A., Gan, L., Cuervo, A. M., and Sulzer, D. (2022) Mutant glucocerebrosidase impairs \u03b1-synuclein degradation by blockade of chaperone-mediated autophagy, Sci. Adv., 8, eabm6393, \nhttps:\/\/doi.org\/10.1126\/sciadv.abm6393.","journal-title":"Sci. Adv."},{"key":"2892_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112180","volume":"42","author":"H. Bogetofte","year":"2023","unstructured":"Bogetofte, H., Ryan, B. J., Jensen, P., Schmidt, S. I., Vergoossen, D. L. E., Barnkob, M. B., Kiani, L. N., Chughtai, U., Heon-Roberts, R., Caiazza, M. C., McGuinness, W., M\u00e1rquez-G\u00f3mez, R., Vowles, J., Bunn, F. S., Brandes, J., Kilfeather, P., Connor, J. P., Fernandes, H. J. R., Caffrey, T. M., Meyer, M., Cowley, S. A., Larsen, M. R., and Wade-Martins, R. (2023) Post-translational proteomics platform identifies neurite outgrowth impairments in Parkinson\u2019s disease GBA-N370S dopamine neurons, Cell Rep., 42, 112180, \nhttps:\/\/doi.org\/10.1016\/j.celrep.2023.112180.","journal-title":"Cell Rep."},{"key":"2892_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241512164","volume":"24","author":"T. Usenko","year":"2023","unstructured":"Usenko, T., Bezrukova, A., Rudenok, M. M., Basharova, K., Shadrina, M. I., Slominsky, P. A., Zakharova, E., and Pchelina, S. (2023) Whole transcriptome analysis of substantia nigra in mice with MPTP-induced parkinsonism bearing defective glucocerebrosidase activity, Int. J. Mol. Sci., 24, 12164, \nhttps:\/\/doi.org\/10.3390\/ijms241512164.","journal-title":"Int. J. Mol. Sci."},{"key":"2892_CR54","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.neuron.2017.12.012","volume":"97","author":"F. Zunke","year":"2018","unstructured":"Zunke, F., Moise, A. C., Belur, N. R., Gelyana, E., Stojkovska, I., Dzaferbegovic, H., Toker, N. J., Jeon, S., Fredriksen, K., and Mazzulli, J. R. (2018) Reversible conformational conversion of \u03b1-synuclein into toxic assemblies by glucosylceramide, Neuron, 97, 92-107.e10, \nhttps:\/\/doi.org\/10.1016\/j.neuron.2017.12.012.","journal-title":"Neuron"},{"key":"2892_CR55","doi-asserted-by":"publisher","first-page":"9617","DOI":"10.1523\/JNEUROSCI.1525-17.2017","volume":"37","author":"Y. V. Taguchi","year":"2017","unstructured":"Taguchi, Y. V., Liu, J., Ruan, J., Pacheco, J., Zhang, X., Abbasi, J., Keutzer, J., Mistry, P. K., and Chandra, S. S. (2017) Glucosylsphingosine promotes \u03b1-synuclein pathology in mutant GBA-associated Parkinson\u2019s disease, J.\u00a0Neurosci., 37, 9617-9631, \nhttps:\/\/doi.org\/10.1523\/JNEUROSCI.1525-17.2017.","journal-title":"J.\u00a0Neurosci."},{"key":"2892_CR56","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.cell.2011.06.001","volume":"146","author":"J. R. Mazzulli","year":"2011","unstructured":"Mazzulli, J. R., Xu, Y. H., Sun, Y., Knight, A. L., McLean, P. J., Caldwell, G. A., Sidransky, E., Grabowski, G. A., and Krainc, D. (2011) Gaucher disease glucocerebrosidase and \u03b1-synuclein form a bidirectional pathogenic loop in synucleinopathies, Cell, 146, 37-52, \nhttps:\/\/doi.org\/10.1016\/j.cell.2011.06.001.","journal-title":"Cell"},{"key":"2892_CR57","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.jns.2015.06.030","volume":"356","author":"C. Noelker","year":"2015","unstructured":"Noelker, C., Lu, L., H\u00f6llerhage, M., Vulinovic, F., Sturn, A., Roscher, R., H\u00f6glinger, G. U., Hirsch, E. C., Oertel, W. H., Alvarez-Fischer, D., and Andreas, H. (2015) Glucocerebrosidase deficiency and mitochondrial impairment in experimental Parkinson disease, J.\u00a0Neurol. Sci., 356, 129-136, \nhttps:\/\/doi.org\/10.1016\/j.jns.2015.06.030.","journal-title":"J.\u00a0Neurol. Sci."},{"key":"2892_CR58","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9050491","volume":"9","author":"J. Fern\u00e1ndez-Irigoyen","year":"2021","unstructured":"Fern\u00e1ndez-Irigoyen, J., Cartas-Cejudo, P., Iruarrizaga-Lejarreta, M., and Santamar\u00eda, E. (2021) Alteration in the cerebrospinal fluid lipidome in Parkinson\u2019s disease: a post-mortem pilot study, Biomedicines, 9, 491, \nhttps:\/\/doi.org\/10.3390\/biomedicines9050491.","journal-title":"Biomedicines"},{"key":"2892_CR59","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1093\/brain\/awac176","volume":"145","author":"J. Galper","year":"2022","unstructured":"Galper, J., Dean, N. J., Pickford, R., Lewis, S. J. G., Halliday, G. M., Kim, W. S., and Dzamko, N. (2022) Lipid pathway dysfunction is prevalent in patients with Parkinson\u2019s disease, Brain, 145, 3472-3487, \nhttps:\/\/doi.org\/10.1093\/brain\/awac176.","journal-title":"Brain"},{"key":"2892_CR60","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/brain\/awab371","volume":"145","author":"C. Galvagnion","year":"2022","unstructured":"Galvagnion, C., Marlet, F. R., Cerri, S., Schapira, A. H. V., Blandini, F., and Di Monte, D. A. (2022) Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote \u03b1-synuclein aggregation, Brain, 145, 1038-1051, \nhttps:\/\/doi.org\/10.1093\/brain\/awab371.","journal-title":"Brain"},{"key":"2892_CR61","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1007\/s12035-021-02688-0","volume":"59","author":"T. S. Usenko","year":"2022","unstructured":"Usenko, T. S., Senkevich, K. A., Bezrukova, A. I., Baydakova, G. V., Basharova, K. S., Zhuravlev, A. S., Gracheva, E. V., Kudrevatykh, A. V., Miliukhina, I. V., Krasakov, I. V., Khublarova, L. A., Fursova, I. V., Zakharov, D. V., Timofeeva, A. A., Irishina, Y. A., Palchikova, E. I., Zalutskaya, N. M., Emelyanov, A. K., Zakharova, E. Y., and Pchelina, S. N. (2022) Impaired sphingolipid hydrolase activities in dementia with Lewy bodies and multiple system atrophy, Mol. Neurobiol., 59, 2277-2287, \nhttps:\/\/doi.org\/10.1007\/s12035-021-02688-0.","journal-title":"Mol. Neurobiol."}],"container-title":["Biochemistry (Moscow)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S000629792560070X.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1134\/S000629792560070X","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1134\/S000629792560070X.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T00:21:42Z","timestamp":1773620502000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1134\/S000629792560070X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["2892"],"URL":"https:\/\/doi.org\/10.1134\/s000629792560070x","relation":{},"ISSN":["0006-2979","1608-3040"],"issn-type":[{"value":"0006-2979","type":"print"},{"value":"1608-3040","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"26 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethics approval and consent to participate.\n                      All animal experiments were performed in accordance with The Guide for the Care and Use of Laboratory Animals. The study was approved by the Ethics Committee of the Institute of Molecular Genetics, Kurchatov Institute National Research Centre (protocol no.\u00a03\\21 from 17.02.2021).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}},{"value":"Conflict of interest.\n                      The authors of this work declare that they have no\u00a0conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declarations"}}]}}